UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Resolution of Recurrent Focal Segmental Glomerulosclerosis Proteinuria after Rituximab Treatment

The New England journal of medicine, 2006-05, Vol.354 (18), p.1961-1963

2006

Volltextzugriff (PDF)

Distinct gene expression pathways in islets from individuals with short‐ and long‐duration type 1 diabetes

Diabetes, obesity & metabolism, 2018-08, Vol.20 (8), p.1859-1867

2018

Volltextzugriff (PDF)

Depletion of the Chimeric Drug Rituximab from Biological Samples

Human immunology, 2017-07, Vol.78 (7-8), p.500-502

2017

Volltextzugriff (PDF)

Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics

Transplantation, 2004-02, Vol.77 (4), p.542

2004

Volltextzugriff (PDF)

Effect of Calcineurin Inhibitors on Posaconazole Blood Levels as Measured by the MVista Microbiological Assay

Antimicrobial Agents and Chemotherapy, 2008-02, Vol.52 (2), p.730-731

2008

Volltextzugriff (PDF)

Rituximab Inhibits the In Vivo Primary and Secondary Antibody Response to a Neoantigen, Bacteriophage phiX174

American journal of transplantation, 2005-01, Vol.5 (1), p.50-57

2005

Volltextzugriff (PDF)

Rituximab, Anti‐CD20, Induces In Vivo Cytokine Release But Does Not Impair Ex Vivo T‐Cell Responses

American journal of transplantation, 2004-08, Vol.4 (8), p.1357-1360

2004

Volltextzugriff (PDF)

229-P Difference in response to new antigen in aged compared to young animals in a murine model

Human immunology, 2011-10, Vol.72, p.S159-S159

2011

Volltextzugriff (PDF)

101-P Presence of alloantibody and ABO antibody in IVIG preparations

Human immunology, 2011-10, Vol.72, p.S84-S84

2011

Volltextzugriff (PDF)

Utility of HbA1c in the detection of subclinical post renal transplant diabetes

Transplantation, 2006-02, Vol.81 (3), p.379-383

2006

Volltextzugriff (PDF)

Pronase treatment facilitates alloantibody flow cytometric and cytotoxic crossmatching in the presence of rituximab

Human immunology, 2004-08, Vol.65 (8), p.803-809

2004

Volltextzugriff (PDF)

270-P: Reduction of alloantibody by BAFF blockade in GFP mice

Human immunology, 2009, Vol.70, p.S147-S147

2009

Volltextzugriff (PDF)

In vivo human B-cell subset recovery after in vivo depletion with rituximab, anti-human CD20 monoclonal antibody

Human antibodies, 2004, Vol.13 (3), p.55-62

2004

Volltextzugriff (PDF)

Removal of therapeutic anti-lymphocyte antibodies from human sera prior to anti-human leukocyte antibody testing

Journal of immunological methods, 2005-05, Vol.300 (1), p.192-199

2005

Volltextzugriff (PDF)

55-P: Impact of anticoagulant in samples for HLA antibody screening by luminex

Human immunology, 2008, Vol.69, p.S35-S35

2008

Volltextzugriff (PDF)

P111 Analysis of hla antibodies after native nephrectomy in renal allograft recipients

Human immunology, 2018-10, Vol.79, p.144-144

2018

Volltextzugriff (PDF)

The Addition of Sirolimus to Cyclosporine and Steroids Inhibits the Anti‐Equine Antibody Response in Renal Transplant Recipients Treated with Antithymocyte Globulin

American journal of transplantation, 2003-04, Vol.3 (4), p.497-500

2003

Volltextzugriff (PDF)

Differential influence of azathioprine and mycophenolate mofetil on the disposition of basiliximab in renal transplant patients

Clinical transplantation, 2001-04, Vol.15 (2), p.123-130

2001

Volltextzugriff (PDF)

Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics1

Transplantation, 2004-02, Vol.77 (4), p.542-548

2004

Volltextzugriff (PDF)

Reduced human IgG anti-ATGAM antibody formation in renal transplant recipients receiving mycophenolate mofetil

Transplantation, 1995-12, Vol.60 (12), p.1379

1995

Volltextzugriff (PDF)

EFFECT OF MYCOPHENOLATE MOFETIL ON THE ANTI-CMV SEROLOGIC RESPONSE AFTER RENAL TRANSPLANTATION: Abstract# 844 Poster Board #-Session: P101-III

Transplantation, 2000-04, Vol.69 (Supplement), p.S331

2000

Volltextzugriff (PDF)

Predictive value of enzyme-linked immunosorbent assay-detected IgG anti-HLA antibodies for pediatric renal allograft rejection

Transplantation, 1997-12, Vol.64 (12), p.1744

1997

Volltextzugriff (PDF)

PREDICTIVE VALUE OF ENZYME-LINKED IMMUNOSORBENT ASSAY-DETECTED IgG ANTI-HLA ANTIBODIES FOR PEDIATRIC RENAL ALLOGRAFT REJECTION1

Transplantation, 1997-12, Vol.64 (12), p.1744-1747

1997

Volltextzugriff (PDF)

REDUCED HUMAN IgG ANTI-ATGAM ANTIBODY FORMATION IN RENAL TRANSPLANT RECIPIENTS RECEIVING MYCOPHENOLATE MOFETIL1,2

Transplantation, 1995-12, Vol.60 (12), p.1379-1383

1995

Volltextzugriff (PDF)

Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment

The New England journal of medicine, 2006, Vol.354 (18), p.1961-1963

2006

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(24)
Berichte
(1)

Sprache

Englisch
(25)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(15)
Life Sciences & Biomedicine
(13)
Science & Technology
(13)
Male
(10)
Adult
(9)
Female
(9)
Middle Aged
(8)
Surgery
(7)
Transplantation
(7)
Antibodies, Monoclonal, Murine-Derived
(6)
Biological And Medical Sciences
(6)
Immunology
(6)
Rituximab
(6)
Allergy And Immunology
(5)
Medical Sciences
(5)
Antibodies, Monoclonal - Therapeutic Use
(4)
Kidney Transplantation - Immunology
(4)
Antibodies, Monoclonal - Pharmacology
(3)
B-Lymphocytes - Immunology
(3)
Child
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Resolution of Recurrent Focal Segmental Glomerulosclerosis Proteinuria after Rituximab Treatment

Distinct gene expression pathways in islets from individuals with short‐ and long‐duration type 1 diabetes

Depletion of the Chimeric Drug Rituximab from Biological Samples

Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics

Effect of Calcineurin Inhibitors on Posaconazole Blood Levels as Measured by the MVista Microbiological Assay

Rituximab Inhibits the In Vivo Primary and Secondary Antibody Response to a Neoantigen, Bacteriophage phiX174

Rituximab, Anti‐CD20, Induces In Vivo Cytokine Release But Does Not Impair Ex Vivo T‐Cell Responses

229-P Difference in response to new antigen in aged compared to young animals in a murine model

101-P Presence of alloantibody and ABO antibody in IVIG preparations

Utility of HbA1c in the detection of subclinical post renal transplant diabetes

Pronase treatment facilitates alloantibody flow cytometric and cytotoxic crossmatching in the presence of rituximab

270-P: Reduction of alloantibody by BAFF blockade in GFP mice

In vivo human B-cell subset recovery after in vivo depletion with rituximab, anti-human CD20 monoclonal antibody

Removal of therapeutic anti-lymphocyte antibodies from human sera prior to anti-human leukocyte antibody testing

55-P: Impact of anticoagulant in samples for HLA antibody screening by luminex

P111 Analysis of hla antibodies after native nephrectomy in renal allograft recipients

The Addition of Sirolimus to Cyclosporine and Steroids Inhibits the Anti‐Equine Antibody Response in Renal Transplant Recipients Treated with Antithymocyte Globulin

Differential influence of azathioprine and mycophenolate mofetil on the disposition of basiliximab in renal transplant patients

Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics1

Reduced human IgG anti-ATGAM antibody formation in renal transplant recipients receiving mycophenolate mofetil

EFFECT OF MYCOPHENOLATE MOFETIL ON THE ANTI-CMV SEROLOGIC RESPONSE AFTER RENAL TRANSPLANTATION: Abstract# 844 Poster Board #-Session: P101-III

Predictive value of enzyme-linked immunosorbent assay-detected IgG anti-HLA antibodies for pediatric renal allograft rejection

PREDICTIVE VALUE OF ENZYME-LINKED IMMUNOSORBENT ASSAY-DETECTED IgG ANTI-HLA ANTIBODIES FOR PEDIATRIC RENAL ALLOGRAFT REJECTION1

REDUCED HUMAN IgG ANTI-ATGAM ANTIBODY FORMATION IN RENAL TRANSPLANT RECIPIENTS RECEIVING MYCOPHENOLATE MOFETIL1,2

Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment

Suchergebnisse filtern